Abstract
Guillain-Barré-Syndrome (GBS) is one of the reported neurological manifestations linked to a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2)(COVID-19). We are presenting a case of a 72-years-old male patient who attended Sultan Qaboos University Hospital with a history of progressive bilateral limbs weakness and numbness. After exclusion of other possible causes, a diagnosis of GBS induced by COVID-19 was made. He received Intravenous Immunoglobulin (IVIG) 0.4g/kg/day for 5 days. This diagnosis is in line with a rare complication of COVID-19. This case highlights the characteristics and the course of GBS following COVID-19 infection. Further studies are needed to characterize the manifestations and the course of various neuromuscular disorders in relation to COVID-19 infection.
Publication Date
8-25-2022
First Page
409
Last Page
412
Creative Commons License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 International License.
Recommended Citation
Al-Zadjali, Mohammed M.; Shibli, Emaad Al; Maskari, Mohammed Al; Gujjar, Arunodaya R.; and Asmi, Abdullah Al
(2022)
"Post COVID-19 Guillain-Barré-Syndrome (GBS),"
Sultan Qaboos University Medical Journal: Vol. 22: 409-412.
DOI: https://doi.org/10.18295/squmj.6.2021.090